04/12/2025
My Blog25
Malawi has approved a new ART(HIV) drug Lenacapavir..
Lenacapavir is an anti-retroviral medicine used to prevent and manage HIV. It is present in both tablet and injection formulations.
The drug is taken after 6 months and thus twice yearly within its recommended dosing.
It works by binding on the HIV-1 virus capsid protein which is a crucial protein in viral uncoating, replication and Assembly and that means this drug prevents all these viral processes.
Side effects include injection site reactions such as swelling, Pain, redness and lumps.
It can also cause changes in the immune system.